April 12, 2022
April 12, 2022 —
UC San Diego study shows chronic JUUL use leads to inflammatory changes across the body, and may affect organs’ response to infection; results depend on e-cigarette flavor.
April 12, 2022
April 12, 2022 —
How do the lungs develop after taking their first breaths outside the womb? What cellular events and changes early in life give rise to lung malfunction and disease? UC San Diego researchers developed a single-cell atlas of postnatal lung development that could help answer these questions.
April 11, 2022
April 11, 2022 —
Researchers at UC San Diego School of Medicine and Moores Cancer Center at UC San Diego Health, with collaborators, have further elucidated how ovarian cancer tumors defy immunotherapy, identifying new molecular targets that might boost immune response.
April 6, 2022
April 6, 2022 —
UC San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.
March 29, 2022
March 29, 2022 —
U.S. News & World Report today released its 2023 Best Graduate Schools rankings, naming graduate programs and professional schools at the University of California San Diego among the best in the country. The rankings placed nine of the campus’s graduate programs among the top 10 in the nation.
March 28, 2022
March 28, 2022 —
UC San Diego Health receives “LGBTQ+ Healthcare Equality Leader” designation by the Human Rights Campaign Foundation for policies and practices dedicated to the equitable treatment and inclusion of LGBTQ+ patients, visitors and employees.
March 22, 2022
March 22, 2022 —
A UC San Diego pilot study on parents of mass shooting victims finds that eight weeks of mindfulness training is effective in reducing trauma, depression, stress and grief caused by gun violence.
March 21, 2022
March 21, 2022 —
UC San Diego study finds new screening tool flags 95 percent of stage 1 pancreatic cancers.
March 21, 2022
March 21, 2022 —
UC San Diego Health is now administering Evusheld to eligible, immunocompromised patients to protect against the COVID-19 virus.
March 17, 2022
March 17, 2022 —
UC San Diego study shows neuroendocrine cells in the lungs drive a developmental lung disease, and a similar brain-lung interaction may contribute to COVID-19 symptoms. The findings suggest neuropeptides may be a promising therapeutic target for conditions with excess lung fluid.
